154 related articles for article (PubMed ID: 26473644)
1. A Prognostic Model to Predict Mortality among Non-Small-Cell Lung Cancer Patients in the U.S. Military Health System.
Lin J; Carter CA; McGlynn KA; Zahm SH; Nations JA; Anderson WF; Shriver CD; Zhu K
J Thorac Oncol; 2015 Dec; 10(12):1694-702. PubMed ID: 26473644
[TBL] [Abstract][Full Text] [Related]
2. Metformin use and survival after non-small cell lung cancer: A cohort study in the US Military health system.
Lin J; Gill A; Zahm SH; Carter CA; Shriver CD; Nations JA; Anderson WF; McGlynn KA; Zhu K
Int J Cancer; 2017 Jul; 141(2):254-263. PubMed ID: 28380674
[TBL] [Abstract][Full Text] [Related]
3. Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy.
Dehing-Oberije C; Yu S; De Ruysscher D; Meersschout S; Van Beek K; Lievens Y; Van Meerbeeck J; De Neve W; Rao B; van der Weide H; Lambin P
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):355-62. PubMed ID: 19095367
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Preexisting Mental Health Disorders on the Diagnosis, Treatment, and Survival among Lung Cancer Patients in the U.S. Military Health System.
Lin J; McGlynn KA; Carter CA; Nations JA; Anderson WF; Shriver CD; Zhu K
Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1564-1571. PubMed ID: 27566418
[TBL] [Abstract][Full Text] [Related]
5. 4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index.
Blanchon F; Grivaux M; Asselain B; Lebas FX; Orlando JP; Piquet J; Zureik M
Lancet Oncol; 2006 Oct; 7(10):829-36. PubMed ID: 17012045
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a prognostic index for survival in non-small cell lung cancer: Results from a Tunisian cohort study.
Soussi G; Ben Alaya N; Chaouch N; Racil H
Cancer Epidemiol; 2018 Apr; 53():111-118. PubMed ID: 29414630
[TBL] [Abstract][Full Text] [Related]
7. Survival and Racial Differences of Non-Small Cell Lung Cancer in the United States Military.
Brzezniak C; Satram-Hoang S; Goertz HP; Reyes C; Gunuganti A; Gallagher C; Carter CA
J Gen Intern Med; 2015 Oct; 30(10):1406-12. PubMed ID: 25805503
[TBL] [Abstract][Full Text] [Related]
8. Survival and risk model for stage IB non-small cell lung cancer.
Padilla J; Calvo V; Peñalver JC; Zarza AG; Pastor J; Blasco E; París F
Lung Cancer; 2002 Apr; 36(1):43-8. PubMed ID: 11891032
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancer.
Alexander M; Wolfe R; Ball D; Conron M; Stirling RG; Solomon B; MacManus M; Officer A; Karnam S; Burbury K; Evans SM
Br J Cancer; 2017 Aug; 117(5):744-751. PubMed ID: 28728168
[TBL] [Abstract][Full Text] [Related]
10. Prognosis in lung cancer: physicians' opinions compared with outcome and a predictive model.
Muers MF; Shevlin P; Brown J
Thorax; 1996 Sep; 51(9):894-902. PubMed ID: 8984699
[TBL] [Abstract][Full Text] [Related]
11. External validation of a prognostic model for mortality among patients with non-small-cell lung cancer using the Veterans Precision Oncology Data Commons.
Cheng D; Ramos-Cejudo J; Tuck D; Elbers D; Brophy M; Do N; Fillmore N
Semin Oncol; 2019; 46(4-5):327-333. PubMed ID: 31708233
[TBL] [Abstract][Full Text] [Related]
12. An updated and validated PET/CT volumetric prognostic index for non-small cell lung cancer.
Finkle JH; Penney BC; Pu Y
Lung Cancer; 2018 Sep; 123():136-141. PubMed ID: 30089584
[TBL] [Abstract][Full Text] [Related]
13. Exploring Stage I non-small-cell lung cancer: development of a prognostic model predicting 5-year survival after surgical resection†.
Guerrera F; Errico L; Evangelista A; Filosso PL; Ruffini E; Lisi E; Bora G; Asteggiano E; Olivetti S; Lausi P; Ardissone F; Oliaro A
Eur J Cardiothorac Surg; 2015 Jun; 47(6):1037-43. PubMed ID: 25391390
[TBL] [Abstract][Full Text] [Related]
14. Survival among Lung Cancer Patients in the U.S. Military Health System: A Comparison with the SEER Population.
Lin J; Kamamia C; Brown D; Shao S; McGlynn KA; Nations JA; Carter CA; Shriver CD; Zhu K
Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):673-679. PubMed ID: 29531129
[No Abstract] [Full Text] [Related]
15. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
Hyun SH; Choi JY; Kim K; Kim J; Shim YM; Um SW; Kim H; Lee KH; Kim BT
Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069
[TBL] [Abstract][Full Text] [Related]
16. Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests.
Zhang K; Lai Y; Axelrod R; Campling B; Hyslop T; Civan J; Solomides C; Myers RE; Lu B; Bar Ad V; Li B; Ye Z; Yang H
Int J Cancer; 2015 Jan; 136(2):382-91. PubMed ID: 24866905
[TBL] [Abstract][Full Text] [Related]
17. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
[TBL] [Abstract][Full Text] [Related]
18. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
[TBL] [Abstract][Full Text] [Related]
19. Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry.
Zhang J; Gold KA; Lin HY; Swisher SG; Xing Y; Lee JJ; Kim ES; William WN
J Thorac Oncol; 2015 Apr; 10(4):682-90. PubMed ID: 25590605
[TBL] [Abstract][Full Text] [Related]
20. Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases.
Guo S; Reddy CA; Chao ST; Suh JH; Barnett GH; Vogelbaum MA; Videtic GM
Lung Cancer; 2012 Aug; 77(2):389-93. PubMed ID: 22542706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
